Case Report
Publish Ahead of Print
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells
Editorial Commentary
Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target
Original Article
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel
Editorial Commentary
Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
Editorial Commentary